Autologous gamma delta T cells targeting PSCA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous gamma delta T cells targeting PSCA, covering 2026-03-31 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC [Phase 1]